Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events

Learning Objectives:

• List special considerations for certain patient populations for initiating therapy and for patients undergoing rechallenge with immune checkpoint inhibitors
• Discuss recognition, monitoring, and management of rare and life-threatening immune-related adverse events (irAEs)
• Review strategies for managing irAEs in the corticosteroid-refractory setting